Showing results (371-380 of 454) with videos related to
Sort By:
Pageof 46
Medicina Oral, Patologia Oral Y Cirugia Bucal|November 28, 2020
PMS2: a potential prognostic protein marker in oral squamous cell carcinomaJ-M Decker, O-V Filho, M-O Freitas, et al.Journal of Biomedical Optics|March 16, 2023
Color-resolved Cherenkov imaging allows for differential signal detection in blood and melanin contentVihan A Wickramasinghe, Savannah M Decker, Samuel S Streeter, et al.ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.Obesity Science & Practice|October 14, 2022
Psychosocial predictors of problematic eating in young adults who underwent adolescent bariatric surgeryKristina M Decker, Jennifer Reiter-Purtill, Carolina M Bejarano, et al.Oncotarget|March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrowYounghun Jung, Ann M Decker, Jingcheng Wang, et al.Journal of Cellular Biochemistry|October 19, 2016
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular DormancyFrank C Cackowski, Matthew R Eber, James Rhee, et al.Journal of Molecular Biology|July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoproteinFrançois Stricher, Chih-chin Huang, Anne Descours, et al.Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.Pageof 46